Goldman Sachs’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.66M | Sell |
9,000
-1,000
| -10% | -$297K | ﹤0.01% | 4276 |
|
|
2025
Q4 | $2.73M | Sell |
10,000
-8,000
| -44% | -$2.17M | ﹤0.01% | 4302 |
|
|
2025
Q3 | $4.86M | Buy |
18,000
+10,000
| +125% | +$2.72M | ﹤0.01% | 3673 |
|
|
2025
Q2 | $2.2M | Buy |
+8,000
| New | +$2.18M | ﹤0.01% | 4100 |
|
|
2023
Q2 | – | Sell |
-23,400
| Closed | -$4.48M | – | 5790 |
|
|
2023
Q1 | $4.48M | Sell |
23,400
-104,000
| -82% | -$18.8M | ﹤0.01% | 3169 |
|
|
2022
Q4 | $21.4M | Buy |
127,400
+44,100
| +53% | +$7.66M | 0.01% | 1889 |
|
|
2022
Q3 | $14.8M | Buy |
83,300
+1,300
| +2% | +$257K | ﹤0.01% | 2137 |
|
|
2022
Q2 | $16.8M | Buy |
82,000
+47,500
| +138% | +$10.1M | ﹤0.01% | 2047 |
|
|
2022
Q1 | $8.21M | Sell |
34,500
-15,300
| -31% | -$3.59M | ﹤0.01% | 2887 |
|
|
2021
Q4 | $11.4M | Sell |
49,800
-78,200
| -61% | -$17.2M | ﹤0.01% | 2641 |
|
|
2021
Q3 | $24.8M | Sell |
128,000
-49,700
| -28% | -$10.1M | 0.01% | 1874 |
|
|
2021
Q2 | $37.8M | Buy |
177,700
+42,200
| +31% | +$8.91M | 0.01% | 1505 |
|
|
2021
Q1 | $27.7M | Buy |
135,500
+67,500
| +99% | +$13.3M | 0.01% | 1656 |
|
|
2020
Q4 | $12.4M | Buy |
68,000
+9,000
| +15% | +$1.53M | ﹤0.01% | 2268 |
|
|
2020
Q3 | $9.87M | Buy |
59,000
+43,100
| +271% | +$7.26M | ﹤0.01% | 2335 |
|
|
2020
Q2 | $2.58M | Buy |
15,900
+12,200
| +330% | +$2.19M | ﹤0.01% | 3276 |
|
|
2020
Q1 | $640K | Sell |
3,700
-4,100
| -53% | -$816K | ﹤0.01% | 4056 |
|
|
2019
Q4 | $1.57M | Buy |
+7,800
| New | +$1.6M | ﹤0.01% | 3818 |
|
|
2019
Q1 | – | Sell |
-6,200
| Closed | -$1.17M | – | 5176 |
|
|
2018
Q4 | $1.17M | Hold |
6,200
| – | – | ﹤0.01% | 3884 |
|
|
2018
Q3 | $1.05M | Buy |
6,200
+3,700
| +148% | +$623K | ﹤0.01% | 4028 |
|
|
2018
Q2 | $410K | Sell |
2,500
-269,000
| -99% | -$43.9M | ﹤0.01% | 4620 |
|
|
2018
Q1 | $43.9M | Buy |
271,500
+97,000
| +56% | +$15.4M | 0.01% | 1288 |
|
|
2017
Q4 | $25.5M | Sell |
174,500
-74,900
| -30% | -$10.7M | 0.01% | 1752 |
|
|
2017
Q3 | $33.8M | Buy |
249,400
+51,400
| +26% | +$6.49M | 0.01% | 1566 |
|
|
2017
Q2 | $24.8M | Sell |
198,000
-72,300
| -27% | -$8.65M | 0.01% | 1768 |
|
|
2017
Q1 | $32.1M | Sell |
270,300
-34,500
| -11% | -$4.15M | 0.01% | 1542 |
|
|
2016
Q4 | $35.2M | Buy |
304,800
+173,200
| +132% | +$19.3M | 0.01% | 1524 |
|
|
2016
Q3 | $13.8M | Sell |
131,600
-159,600
| -55% | -$16.7M | ﹤0.01% | 2195 |
|
|
2016
Q2 | $28.4M | Buy |
291,200
+245,200
| +533% | +$23.2M | 0.01% | 1535 |
|
|
2016
Q1 | $4.42M | Sell |
46,000
-34,200
| -43% | -$3.11M | ﹤0.01% | 2818 |
|
|
2015
Q4 | $7.27M | Sell |
80,200
-15,000
| -16% | -$1.41M | ﹤0.01% | 2516 |
|
|
2015
Q3 | $8.83M | Buy |
95,200
+7,600
| +9% | +$722K | ﹤0.01% | 2347 |
|
|
2015
Q2 | $8.15M | Buy |
87,600
+7,700
| +10% | +$718K | ﹤0.01% | 2513 |
|
|
2015
Q1 | $7.57M | Sell |
79,900
-22,500
| -22% | -$2.08M | ﹤0.01% | 2517 |
|
|
2014
Q4 | $9.08M | Sell |
102,400
-6,100
| -6% | -$517K | ﹤0.01% | 2433 |
|
|
2014
Q3 | $8.68M | Sell |
108,500
-119,700
| -52% | -$9.02M | ﹤0.01% | 2476 |
|
|
2014
Q2 | $16.2M | Buy |
228,200
+103,400
| +83% | +$7.28M | 0.01% | 1966 |
|
|
2014
Q1 | $9.24M | Sell |
124,800
-215,900
| -63% | -$16.3M | ﹤0.01% | 2437 |
|
|
2013
Q4 | $26.7M | Buy |
340,700
+2,300
| +0.7% | +$180K | 0.01% | 1524 |
|
|
2013
Q3 | $25M | Sell |
338,400
-17,700
| -5% | -$1.3M | 0.01% | 1436 |
|
|
2013
Q2 | $27M | Buy |
+356,100
| New | +$23.4M | 0.01% | 1311 |
|
Other funds holding CME
VCM
VPM
Goldman Sachs's CME Position: Q1 2026 in Review
Goldman Sachs increased its CME Group (CME) stake by 11% in Q1 2026, buying an estimated $101M and bringing the position to 3,575,307 shares worth $1.06B. The position accounts for 0.12% of the portfolio, ranked #156.
Goldman Sachs first reported a position in CME in Q2 2013 and has held it in 52 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Goldman Sachs held 3,575,307 shares of CME Group worth $1.06B as of Q1 2026.
- Goldman Sachs bought 341,273 CME Group shares in Q1 2026, an estimated $101M.
- CME Group made up 0.12% of Goldman Sachs's portfolio in Q1 2026, its #156 holding.
- Goldman Sachs first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.